FDA Inspection 1020657 — Grifols d.b.a. Biomat USA, Inc.
The FDA completed an inspection of Grifols d.b.a. Biomat USA, Inc. on July 14, 2017 in Pueblo, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pueblo, CO (United States)